At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 50 target
Drug / intervention
Fecal microbiotabiological
Likely dose
Not stated in record
Key inclusion· 1
- ✓Gut GVHD diagnosis
Key exclusion· 2
- ✕Age greater than 60 years
- ✕Age less than 10 years
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Department of Hematology of First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University·observational·Posted May 11, 2017·Updated Jun 1, 2026
In Brief
An observational study evaluating Fecal microbiota for Acute-graft-versus-host Disease. Currently recruiting, targeting 50 participants across 1 site.
Detailed Summary
With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute-graft-versus-host Disease
CountriesChina
Collaborators--
Timeline
N/ARecruiting
2018201920202021202220232024202520262027202820292030
First PostedMay 2017
Enrollment StartMay 2017
TodayJul 2026
Primary CompletionDec 2028
Study CompletionDec 2029
First PostedMay 11, 2017
Enrollment StartMay 16, 2017
Primary CompletionDec 1, 2028
Study CompletionDec 1, 2029
TodayJul 2, 2026
Enrollment to primary: 11.5 yearsPosted 9.1 years agoPrimary completion in 2.4 years
Interventions
Fecal microbiotabiological
fecal microbiota transplantation